Dr. Potz is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
201 Gibraltar Rd
Ste 120
Horsham, PA 19044Phone+1 215-706-2034Fax+1 215-706-4176
Education & Training
Tufts Medical CenterFellowship, Hematology and Medical Oncology, 1987 - 1992
Beth Israel Deaconess Medical CenterResidency, Internal Medicine, 1982 - 1985
Tufts University School of MedicineClass of 1982
Certifications & Licensure
PA State Medical License 1993 - 2024- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Trial) Start of enrollment: 2006 Apr 07
- Phase IIB/III Of TG4010 Immunotherapy In Patients With Stage IV Non-Small Cell Lung Cancer Start of enrollment: 2012 Apr 01
- Trilaciclib, a CDK 4/6 Inhibitor, in Patients Receiving Gemcitabine and Carboplatin for Metastatic Triple-Negative Breast Cancer (TNBC) Start of enrollment: 2021 Apr 15
- Join now to see all
Publications & Presentations
PubMed
- 712 citationsFunctional regions of the envelope glycoprotein of human immunodeficiency virus type 1Mark Kowalski, Joseph Potz, Ladan Basiripour, Tatyana Dorfman, Wei Chun Goh
Science. 1987-09-11 - 9 citationsMetastatic prostatic adenocarcinoma within a primary solid papillary carcinoma of the male breast.Sunati Sahoo, Roberta E. Smith, Joseph L. Potz, Paul Peter Rosen
Archives of Pathology & Laboratory Medicine. 2001-08-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
